R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy.

Rocio Tejero1, Stefanie Balk2, Julio Franco-Espin1

  • 1Department of Medical Physiology and Biophysics, School of Medicine, University of Seville, 41009 Seville, Spain.

Iscience
|January 26, 2020
PubMed
Summary

R-Roscovitine treatment significantly improved survival and motor function in spinal muscular atrophy (SMA) mice by enhancing calcium signaling and motor neuron health. This drug offers a promising therapeutic avenue for SMA by restoring neuromuscular junction function.